Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS: OTLC · Delayed Price · USD
0.0310
-0.0020 (-6.06%)
Jul 1, 2024, 3:55 PM EDT - Market closed
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $12.39 million as of July 2, 2024. Its market cap has decreased by -53.42% in one year.
Market Cap
12.39M
Enterprise Value
25.50M
1-Year Change
-53.42%
Ranking
n/a
Category
Stock Price
$0.03
Market Cap Chart
Since December 1, 1998, Oncotelic Therapeutics's market cap has decreased from $87.40M to $12.39M, a decrease of -85.82%. That is a compound annual growth rate of -7.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 14, 2023 | 13.20M | -25.00% |
Dec 30, 2022 | 17.60M | -71.88% |
Dec 31, 2021 | 62.60M | 224.35% |
Dec 31, 2020 | 19.30M | 36.88% |
Dec 31, 2019 | 14.10M | 487.50% |
Dec 31, 2018 | 2.40M | -40.00% |
Dec 29, 2017 | 4.00M | -58.33% |
Dec 30, 2016 | 9.60M | -52.48% |
Dec 31, 2015 | 20.20M | -39.34% |
Dec 31, 2014 | 33.30M | 321.52% |
Dec 31, 2013 | 7.90M | -14.13% |
Dec 31, 2012 | 9.20M | -37.41% |
Dec 30, 2011 | 14.70M | -40.73% |
Dec 31, 2010 | 24.80M | -65.17% |
Dec 31, 2009 | 71.20M | 208.23% |
Dec 31, 2008 | 23.10M | -67.46% |
Dec 31, 2007 | 71.00M | -47.52% |
Dec 29, 2006 | 135.30M | 65.81% |
Dec 30, 2005 | 81.60M | -11.30% |
Dec 31, 2004 | 92.00M | -20.62% |
Dec 31, 2003 | 115.90M | 771.43% |
Dec 31, 2002 | 13.30M | -62.11% |
Dec 31, 2001 | 35.10M | -47.46% |
Dec 29, 2000 | 66.80M | -58.35% |
Dec 31, 1999 | 160.40M | 46.22% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 860.48B |
Novo Nordisk | 629.27B |
UnitedHealth Group | 468.72B |
Johnson & Johnson | 351.76B |
Merck & Co. | 313.56B |
AbbVie | 302.88B |
AstraZeneca | 241.81B |
Thermo Fisher | 211.09B |